Who developed QuantiFERON®-TB Gold In-Tube test?
Cellestis Limited, a listed Australian biotechnology company founded in 2000 in Melbourne, Australia, develops and manufactures the QuantiFERON®-TB Gold In-Tube test, a breakthrough blood test for the detection and control of tuberculosis. The QuantiFERON®-TB Gold technology is a patented method for detecting cell mediated immune (CMI) responses of T-cell lymphocytes using whole blood samples. QuantiFERON®-TB Gold test is available nationally through Quest Diagnostics. The performance of the USA format of the QuantiFERON®-TB Gold IT test has not been extensively evaluated with specimens from the following groups of individuals:7 • Individuals who have impaired or altered immune function such as those who have HIV infection or AIDS, those who have transplantation managed with immunosuppressive treatment or others who receive immunosuppressive drugs (e.g. corticosteroids, methotrexate, azathioprine, cancer chemotherapy), and those who have other clinical conditions: diabetes, silicosis,
